Yasodha Natkunam, M.D., Ph.D

Pathologist, Hematopathologist, Surgical pathologist, Immunodiagnosis pathologist

Professor of Pathology at Stanford University Medical Center

Professional Education

Medical Education: Mt Sinai School of Medicine (1995) NY

Internship: Stanford University School of Medicine (1996) CA

Residency: Stanford University School of Medicine (2000) CA

Board Certification: Anatomic Pathology, American Board of Pathology (1998)

PhD, Mt.Sinai School of Medicine, Molecular Biology (1993)

AB, Bryn Mawr College, Biology (1987)

Administrative Appointments

Associate Chair for Hematopathology, Stanford (2009 - Present)

Program Director, Hematopathology Fellowship, Stanford (2009 - Present)

Associate Chair for Faculty Development and Diversity, Stanford (2009 - Present)

Co-Director, Immunodiagnosis Laboratory, Stanford (2005 - Present)

Germinal centre protein HGAL promotes lymphoid hyperplasia and amyloidosis via BCR-mediated Syk activation.
Romero-Camarero, I., Jiang, X., Natkunam, Y., Lu, X., Vicente-Dueñas, C., & Lossos, I. S. (2013). Germinal centre protein HGAL promotes lymphoid hyperplasia and amyloidosis via BCR-mediated Syk activation. Nature communications, 4, 1338-?.

Bevacizumab and cyclosphosphamide, doxorubicin, vincristine and prednisone in combination for patients with peripheral T-cell or natural killer cell neoplasms: an Eastern Cooperative Oncology Group study (E2404).
Ganjoo, K., Hong, F., Horning, S. J., Gascoyne, R. D., Natkunam, Y., & Advani, R. H. (2014). Bevacizumab and cyclosphosphamide, doxorubicin, vincristine and prednisone in combination for patients with peripheral T-cell or natural killer cell neoplasms: an Eastern Cooperative Oncology Group study (E2404). Leukemia & lymphoma, 55(4), 768-772.

Mature results of a phase II study of rituximab therapy for nodular lymphocyte-predominant Hodgkin lymphoma.
Advani, R. H., Horning, S. J., Hoppe, R. T., Daadi, S., Allen, J., & Bartlett, N. L. (2014). Mature results of a phase II study of rituximab therapy for nodular lymphocyte-predominant Hodgkin lymphoma. Journal of clinical oncology , 32(9), 912-918.

LMO2 (LIM domain only 2) is expressed in a subset of acute myeloid leukaemia and correlates with normal karyotype
Patel, J. L., Pournazari, P., Haggstrom, S.-J., Kosari, F., Shabani-Rad, M.-T., & Mansoor, A. (2014). LMO2 (LIM domain only 2) is expressed in a subset of acute myeloid leukaemia and correlates with normal karyotype. HISTOPATHOLOGY, 64(2), 226-233.

Expression of the Activating Receptor, NKp46 (CD335), in Human Natural Killer and T-Cell Neoplasia.
Freud, A. G., Zhao, S., Wei, S., Gitana, G. M., Molina-Kirsch, H. F., & Natkunam, Y. (2013). Expression of the Activating Receptor, NKp46 (CD335), in Human Natural Killer and T-Cell Neoplasia. American journal of clinical pathology, 140(6), 853-866.

Molecular and genomic aberrations in Chlamydophila psittaci negative ocular adnexal marginal zone lymphomas
Zhu, D., Ikpatt, O. F., Dubovy, S. R., Lossos, C., Natkunam, Y., & Lossos, I. S. (2013). Molecular and genomic aberrations in Chlamydophila psittaci negative ocular adnexal marginal zone lymphomas. AMERICAN JOURNAL OF HEMATOLOGY, 88(9), 730-735.

LITAF, a BCL6 target gene, regulates autophagy in mature B-cell lymphomas
Bertolo, C., Roa, S., Sagardoy, A., Mena-Varas, M., Robles, E. F., & Martinez-Climent, J. A. (2013). LITAF, a BCL6 target gene, regulates autophagy in mature B-cell lymphomas. BRITISH JOURNAL OF HAEMATOLOGY, 162(5), 621-630.

CD30 targeting with brentuximab vedotin: a novel therapeutic approach to primary effusion lymphoma
Bhatt, S., Ashlock, B. M., Natkunam, Y., Sujoy, V., Chapman, J. R., & Lossos, I. S. (2013). CD30 targeting with brentuximab vedotin: a novel therapeutic approach to primary effusion lymphoma. BLOOD, 122(7), 1233-1242.

Improvements in observed and relative survival in follicular grade 1-2 lymphoma during 4 decades: the Stanford University experience.
Tan, D., Horning, S. J., Hoppe, R. T., Levy, R., Rosenberg, S. A., & Advani, R. H. (2013). Improvements in observed and relative survival in follicular grade 1-2 lymphoma during 4 decades: the Stanford University experience. Blood, 122(6), 981-987.

Clinicopathological features of aggressive B-cell lymphomas including B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell and Burkitt lymphomas: a study of 44 patients from Argentina.
Bürgesser, M. V., Gualco, G., Diller, A., Natkunam, Y., & Bacchi, C. E. (2013). Clinicopathological features of aggressive B-cell lymphomas including B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell and Burkitt lymphomas: a study of 44 patients from Argentina. Annals of diagnostic pathology, 17(3), 250-255.

Usefulness of HGAL and LMO2 Immunohistochemistry in the Identification of Follicular Lymphomas of the Non-Gastric Gastrointestinal Tract
Chapman-Fredricks, J., Younes, S. F., Fan, Y.-S., Sandoval-Sus, J. D., Natkunam, Y., & Lossos, I. S. (2013). Usefulness of HGAL and LMO2 Immunohistochemistry in the Identification of Follicular Lymphomas of the Non-Gastric Gastrointestinal Tract. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 21(3), 200-204.

Indolent T-Lymphoblastic Proliferation (iT-LBP): A Review of Clinical and Pathologic Features and Distinction from Malignant T-Lymphoblastic Lymphoma
Ohgami, R. S., Arber, D. A., Zehnder, J. L., Natkunam, Y., & Warnke, R. A. (2013). Indolent T-Lymphoblastic Proliferation (iT-LBP): A Review of Clinical and Pathologic Features and Distinction from Malignant T-Lymphoblastic Lymphoma. ADVANCES IN ANATOMIC PATHOLOGY, 20(3), 137-140.

The spectrum of lymphoblastic, nodal and extranodal T-cell lymphomas: characteristic features and diagnostic dilemmas
Savage, N. M., Johnson, R. C., & Natkunam, Y. (2013). The spectrum of lymphoblastic, nodal and extranodal T-cell lymphomas: characteristic features and diagnostic dilemmas. HUMAN PATHOLOGY, 44(4), 451-471.

Syk-Induced Phosphatidylinositol-3-Kinase Activation in EpsteinBarr Virus Posttransplant Lymphoproliferative Disorder
Hatton, O., Lambert, S. L., Phillips, L. K., Vaysberg, M., Natkunam, Y., & Martinez, O. M. (2013). Syk-Induced Phosphatidylinositol-3-Kinase Activation in EpsteinBarr Virus Posttransplant Lymphoproliferative Disorder. AMERICAN JOURNAL OF TRANSPLANTATION, 13(4), 883-890.

Integration of genomic medicine into pathology residency training: the stanford open curriculum.
Schrijver, I., Natkunam, Y., Galli, S., & Boyd, S. D. (2013). Integration of genomic medicine into pathology residency training: the stanford open curriculum. journal of molecular diagnostics , 15(2), 141-148.

Selective immunophenotyping for diagnosis of B-cell neoplasms: immunohistochemistry and flow cytometry strategies and results.
Boyd, S. D., Natkunam, Y., Allen, J. R., & Warnke, R. A. (2013). Selective immunophenotyping for diagnosis of B-cell neoplasms: immunohistochemistry and flow cytometry strategies and results. Applied immunohistochemistry & molecular morphology , 21(2), 116-131.

CD137 Ligand Is Expressed in Primary and Secondary Lymphoid Follicles and in B-cell Lymphomas Diagnostic and Therapeutic Implications
Zhao, S., Zhang, H., Xing, Y., & Natkunam, Y. (2013). CD137 Ligand Is Expressed in Primary and Secondary Lymphoid Follicles and in B-cell Lymphomas Diagnostic and Therapeutic Implications. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 37(2), 250-258.

FHIT, EGFR, and MSH2: Possible Etiopathologic, Prognostic, and Predictive Role in Non-Small Cell Lung Carcinoma in Egyptian Patients.
Younes, S. F., Aiad, H. A., Asaad, N. Y., Natkunam, Y., & Mokhtar, N. M. (2013). FHIT, EGFR, and MSH2: Possible Etiopathologic, Prognostic, and Predictive Role in Non-Small Cell Lung Carcinoma in Egyptian Patients. Applied immunohistochemistry & molecular morphology : AIMM / official publication of the Society for Applied Immunohistochemistry.

Follicular lymphoma in young adults: a clinicopathological and molecular study of 200 patients.
Duarte, I. X., Domeny-Duarte, P., Wludarski, S. C., Natkunam, Y., & Bacchi, C. E. (2013). Follicular lymphoma in young adults: a clinicopathological and molecular study of 200 patients. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

TdT(+) T-lymphoblastic Populations Are Increased in Castleman Disease, in Castleman Disease in Association With Follicular Dendritic Cell Tumors, and in Angioimmunoblastic T-cell Lymphoma
Ohgami, R. S., Zhao, S., Ohgami, J. K., Leavitt, M. O., Zehnder, J. L., & Warnke, R. A. (2012). TdT(+) T-lymphoblastic Populations Are Increased in Castleman Disease, in Castleman Disease in Association With Follicular Dendritic Cell Tumors, and in Angioimmunoblastic T-cell Lymphoma. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 36(11), 1619-1628.

The contribution of HGAL/GCET2 in immunohistological algorithms: a comparative study in 424 cases of nodal diffuse large B-cell lymphoma
Gualco, G., Bacchi, L. M., Domeny-Duarte, P., Natkunam, Y., & Bacchi, C. E. (2012). The contribution of HGAL/GCET2 in immunohistological algorithms: a comparative study in 424 cases of nodal diffuse large B-cell lymphoma. MODERN PATHOLOGY, 25(11), 1439-1445.

Cyclin D3 coordinates the cell cycle during differentiation to regulate erythrocyte size and number
Sankaran, V. G., Ludwig, L. S., Sicinska, E., Xu, J., Bauer, D. E., & Lodish, H. F. (2012). Cyclin D3 coordinates the cell cycle during differentiation to regulate erythrocyte size and number. GENES & DEVELOPMENT, 26(18), 2075-2087.

CD137 Is Expressed in Follicular Dendritic Cell Tumors and in Classical Hodgkin and T-Cell Lymphomas Diagnostic and Therapeutic Implications
Anderson, M. W., Zhao, S., Freud, A. G., Czerwinski, D. K., Kohrt, H., & Natkunam, Y. (2012). CD137 Is Expressed in Follicular Dendritic Cell Tumors and in Classical Hodgkin and T-Cell Lymphomas Diagnostic and Therapeutic Implications. AMERICAN JOURNAL OF PATHOLOGY, 181(3), 795-803.

Identification of LMO2 transcriptome and interactome in diffuse large B-cell lymphoma
Cubedo, E., Gentles, A. J., Huang, C., Natkunam, Y., Bhatt, S., & Lossos, I. S. (2012). Identification of LMO2 transcriptome and interactome in diffuse large B-cell lymphoma. BLOOD, 119(23), 5478-5491.

LIM domain only 2 protein expression, LMO2 germline genetic variation, and overall survival in diffuse large B-cell lymphoma in the pre-rituximab era
Cerhan, J. R., Natkunam, Y., Morton, L. M., Maurer, M. J., Asmann, Y., & Wang, S. S. (2012). LIM domain only 2 protein expression, LMO2 germline genetic variation, and overall survival in diffuse large B-cell lymphoma in the pre-rituximab era. LEUKEMIA & LYMPHOMA, 53(6), 1105-1112.

IgG4-Related Systemic Sclerosing Disease of the Ocular Adnexa A Potential Mimic of Ocular Lymphoma
Karamchandani, J. R., Younes, S. F., Warnke, R. A., & Natkunam, Y. (2012). IgG4-Related Systemic Sclerosing Disease of the Ocular Adnexa A Potential Mimic of Ocular Lymphoma. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 137(5), 699-711.

The spectrum of B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma: a description of 10 cases
Gualco, G., Natkunam, Y., & Bacchi, C. E. (2012). The spectrum of B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma: a description of 10 cases. MODERN PATHOLOGY, 25(5), 661-674.

Aggressive EBV-associated Lymphoproliferative Disorder: A Prodrome to Diffuse Large B-cell Lymphoma?
Batra, R., Medeiros, B. C., Zehnder, J. L., Warnke, R. A., & Natkunam, Y. (2012). Aggressive EBV-associated Lymphoproliferative Disorder: A Prodrome to Diffuse Large B-cell Lymphoma?. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 20(3), 325-330.

Expression of the CD2AP adaptor molecule in normal, reactive and neoplastic human tissue.
Rizvi, H., Paterson, J. C., Tedoldi, S., Ramsay, A., Calaminici, M., & Marafioti, T. (2012). Expression of the CD2AP adaptor molecule in normal, reactive and neoplastic human tissue. Pathologica, 104(2), 56-64.

Lack of association of tumor-associated macrophages with clinical outcome in patients with classical Hodgkin's lymphoma
Azambuja, D., Natkunam, Y., Biasoli, I., Lossos, I. S., ANDERSON, M. W., & Spector, N. (2012). Lack of association of tumor-associated macrophages with clinical outcome in patients with classical Hodgkin's lymphoma. ANNALS OF ONCOLOGY, 23(3), 736-742.

Immunostaining to identify molecular subtypes of diffuse large B-cell lymphoma in a population-based epidemiologic study in the pre-rituximab era.
Morton, L. M., Cerhan, J. R., Hartge, P., Vasef, M. A., Neppalli, V. T., & Wang, S. S. (2011). Immunostaining to identify molecular subtypes of diffuse large B-cell lymphoma in a population-based epidemiologic study in the pre-rituximab era. International journal of molecular epidemiology and genetics, 2(3), 245-252.

Prediction of survival in diffuse large B-cell lymphoma based on the expression of 2 genes reflecting tumor and microenvironment
Alizadeh, A. A., Gentles, A. J., Alencar, A. J., Liu, C. L., Kohrt, H. E., & Levy, R. (2011). Prediction of survival in diffuse large B-cell lymphoma based on the expression of 2 genes reflecting tumor and microenvironment. BLOOD, 118(5), 1350-1358.

Clinicopathologic and Molecular Features of 122 Brazilian Cases of Nodal and Extranodal NK/T-Cell Lymphoma, Nasal Type, With EBV Subtyping Analysis
Gualco, G., Domeny-Duarte, P., Chioato, L., Barber, G., Natkunam, Y., & Bacchi, C. E. (2011). Clinicopathologic and Molecular Features of 122 Brazilian Cases of Nodal and Extranodal NK/T-Cell Lymphoma, Nasal Type, With EBV Subtyping Analysis. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 35(8), 1195-1203.

MicroRNAs Are Independent Predictors of Outcome in Diffuse Large B-Cell Lymphoma Patients Treated with R-CHOP
Alencar, A. J., Malumbres, R., Kozloski, G. A., Advani, R., Talreja, N., & Lossos, I. S. (2011). MicroRNAs Are Independent Predictors of Outcome in Diffuse Large B-Cell Lymphoma Patients Treated with R-CHOP. CLINICAL CANCER RESEARCH, 17(12), 4125-4135.

LMO2 protein expression predicts survival in patients with rheumatoid arthritis and diffuse large B-cell lymphoma
Baecklund, E., Backlin, C., Mansouri, M., Klareskog, L., Askling, J., & Rosenquist, R. (2011). LMO2 protein expression predicts survival in patients with rheumatoid arthritis and diffuse large B-cell lymphoma. LEUKEMIA & LYMPHOMA, 52(6), 1146-1149.

HGAL Protein Expression Persists in Disorders of Germinal Center Dissolution Potential Role of HGAL in the Germinal Center Microenvironment
Temmins, C., Zhao, S., Lossos, I. S., & Natkunam, Y. (2011). HGAL Protein Expression Persists in Disorders of Germinal Center Dissolution Potential Role of HGAL in the Germinal Center Microenvironment. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 19(3), 266-272.

The Efficacy of HGAL and LMO2 in the Separation of Lymphomas Derived From Small B Cells in Nodal and Extranodal Sites, Including the Bone Marrow
Younes, S. F., Beck, A. H., Ohgami, R. S., Lossos, I. S., Levy, R., & Natkunam, Y. (2011). The Efficacy of HGAL and LMO2 in the Separation of Lymphomas Derived From Small B Cells in Nodal and Extranodal Sites, Including the Bone Marrow. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 135(5), 697-708.

T-cell lymphomas: a tale of heterogeneity masking clarity
Natkunam, Y. (2011). T-cell lymphomas: a tale of heterogeneity masking clarity. LEUKEMIA & LYMPHOMA, 52(1), 1-2.

Programmed death 1 expression in variant immunoarchitectural patterns of nodular lymphocyte predominant Hodgkin lymphoma: comparison with CD57 and lymphomas in the differential diagnosis
Churchill, H. Ro., Roncador, G., Warnke, R. A., & Natkunam, Y. (2010). Programmed death 1 expression in variant immunoarchitectural patterns of nodular lymphocyte predominant Hodgkin lymphoma: comparison with CD57 and lymphomas in the differential diagnosis. HUMAN PATHOLOGY, 41(12), 1726-1734.

Oral and Extraoral Plasmablastic Lymphoma Similarities and Differences in Clinicopathologic Characteristics
Hansra, D., Montague, N., Stefanovic, A., Akunyili, I., Harzand, A., & Lossos, I. S. (2010). Oral and Extraoral Plasmablastic Lymphoma Similarities and Differences in Clinicopathologic Characteristics. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 134(5), 710-719.

Immunoarchitectural Patterns in Follicular Lymphoma: Efficacy of HGAL and LMO2 in the Detection of the Interfollicular and Diffuse Components
Younes, S. F., Beck, A. H., Lossos, I. S., Levy, R., Warnke, R. A., & Natkunam, Y. (2010). Immunoarchitectural Patterns in Follicular Lymphoma: Efficacy of HGAL and LMO2 in the Detection of the Interfollicular and Diffuse Components. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 34(9), 1266-1276.

Expression of LMO2 Is Associated With t(14;18)/IGH-BCL2 Fusion but Not BCL6 Translocations in Diffuse Large B-Cell Lymphoma
Durnick, D. K., Law, M. E., Maurer, M. J., Natkunam, Y., Levy, R., & McPhail, E. D. (2010). Expression of LMO2 Is Associated With t(14;18)/IGH-BCL2 Fusion but Not BCL6 Translocations in Diffuse Large B-Cell Lymphoma. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 134(2), 278-281.

Efficacy of bortezomib in a direct xenograft model of primary effusion lymphoma
Sarosiek, K. A., Cavallin, L. E., Bhatt, S., Toomey, N. L., Natkunam, Y., & Lossos, I. S. (2010). Efficacy of bortezomib in a direct xenograft model of primary effusion lymphoma. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 107(29), 13069-13074.

Embryonic Stem Cell-Derived Endothelial Cells Engraft Into the Ischemic Hindlimb and Restore Perfusion
Huang, N. F., Niiyama, H., Peter, C., De, A., Natkunam, Y., & Cooke, J. P. (2010). Embryonic Stem Cell-Derived Endothelial Cells Engraft Into the Ischemic Hindlimb and Restore Perfusion. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 30(5), 984-U224.

C-C Chemokine Receptor 1 Expression in Human Hematolymphoid Neoplasia
Anderson, M. W., Zhao, S., Ai, W. Z., Tibshirani, R., Levy, R., & Natkunam, Y. (2010). C-C Chemokine Receptor 1 Expression in Human Hematolymphoid Neoplasia. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 133(3), 473-483.

The inducible T-cell co-stimulator molecule is expressed on subsets of T cells and is a new marker of lymphomas of T follicular helper cell-derivation
Marafioti, T., Paterson, J. C., Ballabio, E., Chott, A., Natkunam, Y., & Gaulardll, P. (2010). The inducible T-cell co-stimulator molecule is expressed on subsets of T cells and is a new marker of lymphomas of T follicular helper cell-derivation. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 95(3), 432-439.

Characterization of D-cyclin proteins in hematolymphoid neoplasms: lack of specificity of cyclin-D2 and D3 expression in lymphoma subtypes
Metcalf, R. A., Zhao, S., Anderson, M. W., Lu, Z. S., Galperin, I., & Natkunam, Y. (2010). Characterization of D-cyclin proteins in hematolymphoid neoplasms: lack of specificity of cyclin-D2 and D3 expression in lymphoma subtypes. MODERN PATHOLOGY, 23(3), 420-433.

PD-1 Expression in T-cell Lymphomas and Reactive Lymphoid Entities: Potential Overlap in Staining Patterns Between Lymphoma and Viral Lymphadenitis
Krishnan, C., Warnke, R. A., Arber, D. A., & Natkunam, Y. (2010). PD-1 Expression in T-cell Lymphomas and Reactive Lymphoid Entities: Potential Overlap in Staining Patterns Between Lymphoma and Viral Lymphadenitis. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 34(2), 178-189.

CD81 protein is expressed at high levels in normal germinal center B cells and in subtypes of human lymphomas
Luo, R. F., Zhao, S., Tibshirani, R., Myklebust, J. H., Sanyal, M., & Natkunam, Y. (2010). CD81 protein is expressed at high levels in normal germinal center B cells and in subtypes of human lymphomas. HUMAN PATHOLOGY, 41(2), 271-280.

Lymphoma cell VEGFR2 expression detected by immunohistochemistry predicts poor overall survival in diffuse large B cell lymphoma treated with immunochemotherapy (R-CHOP)
Gratzinger, D., Advani, R., Zhao, S., Talreja, N., Tibshirani, R. J., & Natkunam, Y. (2010). Lymphoma cell VEGFR2 expression detected by immunohistochemistry predicts poor overall survival in diffuse large B cell lymphoma treated with immunochemotherapy (R-CHOP). BRITISH JOURNAL OF HAEMATOLOGY, 148(2), 235-244.

Building "tissue" microarrays from suspension cells.
Zhao, S., & Natkunam, Y. (2010). Building "tissue" microarrays from suspension cells. Methods in molecular biology (Clifton, N.J.), 664, 93-101.

Microtubule-associated Protein-2 is a Sensitive Marker of Primary and Metastatic Neuroblastoma
Krishnan, C., Higgins, J. P., West, R. B., Natkunam, Y., Heerema-McKenney, A., & Arber, D. A. (2009). Microtubule-associated Protein-2 is a Sensitive Marker of Primary and Metastatic Neuroblastoma. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 33(11), 1695-1704.

Extracellular Signal-Regulated Kinase Positively Regulates the Oncogenic Activity of MCT-1 in Diffuse Large B-Cell Lymphoma
Dai, B., Zhao, X. F., Hagner, P., Shapiro, P., Mazan-Mamczarz, K., & Gartenhaus, R. B. (2009). Extracellular Signal-Regulated Kinase Positively Regulates the Oncogenic Activity of MCT-1 in Diffuse Large B-Cell Lymphoma. CANCER RESEARCH, 69(19), 7835-7843.

Characterization of c-Maf Transcription Factor in Normal and Neoplastic Hematolymphoid Tissue and Its Relevance in Plasma Cell Neoplasia
Natkunam, Y., Tedoldi, S., Paterson, J. C., Zhao, S., Rodriguez-Justo, M., & Marafloti, T. (2009). Characterization of c-Maf Transcription Factor in Normal and Neoplastic Hematolymphoid Tissue and Its Relevance in Plasma Cell Neoplasia. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 132(3), 361-371.

Immunoarchitectural Patterns in Nodal Marginal Zone B-Cell Lymphoma A Study of 51 Cases
Salama, M. E., Lossos, I. S., Warnke, R. A., & Natkunam, Y. (2009). Immunoarchitectural Patterns in Nodal Marginal Zone B-Cell Lymphoma A Study of 51 Cases. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 132(1), 39-49.

Nanofluidic proteomic assay for serial analysis of oncoprotein activation in clinical specimens
Fan, A. C., Deb-Basu, D., Orban, M. W., Gotlib, J. R., Natkunam, Y., & Felsher, D. W. (2009). Nanofluidic proteomic assay for serial analysis of oncoprotein activation in clinical specimens. NATURE MEDICINE, 15(5), 566-571.

Low Stage Follicular Lymphoma: Biologic and Clinical Characterization According to Nodal or Extranodal Primary Origin
Weinberg, O. K., Ma, L., Seo, K., Beck, A. H., Pai, R. K., & Arber, D. A. (2009). Low Stage Follicular Lymphoma: Biologic and Clinical Characterization According to Nodal or Extranodal Primary Origin. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 33(4), 591-598.

Lack of Utility of CD20 Immunohistochemistry in Staging Bone Marrow Biopsies for Diffuse Large B-cell Lymphoma
Baiyee, D., Warnke, R., & Natkunam, Y. (2009). Lack of Utility of CD20 Immunohistochemistry in Staging Bone Marrow Biopsies for Diffuse Large B-cell Lymphoma. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 17(2), 93-95.

The Transcription Factor LMO2 Is a Robust Marker of Vascular Endothelium and Vascular Neoplasms and Selected Other Entities
Gratzinger, D., Zhao, S., West, R., Rouse, R. V., Vogel, H., & Natkunam, Y. (2009). The Transcription Factor LMO2 Is a Robust Marker of Vascular Endothelium and Vascular Neoplasms and Selected Other Entities. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 131(2), 264-278.

Gray zones around diffuse large B cell lymphoma. Conclusions based on the workshop of the XIV meeting of the European Association for Hematopathology and the Society of Hematopathology in Bordeaux, France.
Quintanilla-Martinez, L., De Jong, D., de Mascarel, A., Hsi, E. D., Kluin, P., & Ott, G. (2009). Gray zones around diffuse large B cell lymphoma. Conclusions based on the workshop of the XIV meeting of the European Association for Hematopathology and the Society of Hematopathology in Bordeaux, France. Journal of hematopathology, 2(4), 211-236.

Human germinal center-associated lymphoma protein expression is associated with improved failure-free survival in Brazilian patients with classical Hodgkin lymphoma
Azambuja, D., Lossos, I. S., Biasoli, I., Morais, J. C., Britto, L., & Spector, N. (2009). Human germinal center-associated lymphoma protein expression is associated with improved failure-free survival in Brazilian patients with classical Hodgkin lymphoma. LEUKEMIA & LYMPHOMA, 50(11), 1830-1836.

PTP1B is a negative regulator of interleukin 4-induced STAT6 signaling
Lu, X., Malumbres, R., Shields, B., Jiang, X., Sarosiek, K. A., & Lossos, I. S. (2008). PTP1B is a negative regulator of interleukin 4-induced STAT6 signaling. BLOOD, 112(10), 4098-4108.

Immunohistochemical characterization of nasal-type extranodal NK/T-Cell lymphoma using a tissue microarray
Schwartz, E. J., Molina-Kirsch, H., Zhao, S., Marinelli, R. J., Warnke, R. A., & Natkunam, Y. (2008). Immunohistochemical characterization of nasal-type extranodal NK/T-Cell lymphoma using a tissue microarray. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 130(3), 343-351.

Tissue microarrays from bone marrow aspirates for high-throughput assessment of immunohistologic markers in pediatric acute leukemia
Hazard, F. K., Zhao, S., Schiffman, J. D., Lacayo, N. J., Dahl, G. V., & Natkunam, Y. (2008). Tissue microarrays from bone marrow aspirates for high-throughput assessment of immunohistologic markers in pediatric acute leukemia. PEDIATRIC AND DEVELOPMENTAL PATHOLOGY, 11(4), 283-290.

Paraffin-based 6-gene model predicts outcome in diffuse large B-cell lymphoma patients treated with R-CHOP
Malumbres, R., Chen, J., Tibshirani, R., Johnson, N. A., Sehn, L. H., & Lossos, I. S. (2008). Paraffin-based 6-gene model predicts outcome in diffuse large B-cell lymphoma patients treated with R-CHOP. BLOOD, 111(12), 5509-5514.

Expression of HGAL in primary cutaneous large B-cell lymphomas: evidence for germinal center derivation of primary cutaneous follicular lymphoma
Xie, X., Sundram, U., Natkunam, Y., Kohler, S., Hoppe, R. T., & Hsi, E. D. (2008). Expression of HGAL in primary cutaneous large B-cell lymphomas: evidence for germinal center derivation of primary cutaneous follicular lymphoma. MODERN PATHOLOGY, 21(6), 653-659.

Expression of the human germinal-centre-associated lymphoma protein in diffuse large B-cell lymphomas in patients with rheumatoid arthritis
Baecklund, E., Natkunam, Y., Backlin, C., Iliadou, A., Askling, J., & Rosenquist, R. (2008). Expression of the human germinal-centre-associated lymphoma protein in diffuse large B-cell lymphomas in patients with rheumatoid arthritis. BRITISH JOURNAL OF HAEMATOLOGY, 141(1), 69-72.

LMO2 protein expression predicts survival in patients with diffuse large B-Cell lymphoma treated with anthracycline-based chemotherapy with and without rituximab
Natkunam, Y., Farinha, P., Hsi, E. D., Hans, C. P., Tibshirani, R., & Lossos, I. S. (2008). LMO2 protein expression predicts survival in patients with diffuse large B-Cell lymphoma treated with anthracycline-based chemotherapy with and without rituximab. JOURNAL OF CLINICAL ONCOLOGY, 26(3), 447-454.

Prognostic significance of VEGF, VEGF receptors, and microvessel density in diffuse large B cell lymphoma treated with anthracycline-based chemotherapy
Gratzinger, D., Zhao, S., Tibshirani, R. J., Hsi, E. D., Hans, C. P., & Natkunam, Y. (2008). Prognostic significance of VEGF, VEGF receptors, and microvessel density in diffuse large B cell lymphoma treated with anthracycline-based chemotherapy. LABORATORY INVESTIGATION, 88(1), 38-47.

The Stanford Tissue Microarray Database
Marinelli, R. J., Montgomery, K., Liu, C. L., Shah, N. H., Prapong, W., & Ball, C. A. (2008). The Stanford Tissue Microarray Database. NUCLEIC ACIDS RESEARCH, 36, D871-D877.

Selective loss of B-cell phenotype in lymphocyte predominant Hodgkin lymphoma
Tedoldi, S., Mottok, A., Ying, J., Paterson, J. C., Cui, Y., & Marafioti, T. (2007). Selective loss of B-cell phenotype in lymphocyte predominant Hodgkin lymphoma. JOURNAL OF PATHOLOGY, 213(4), 429-440.

The utility of PAX5 immunohistochemistry in the diagnosis of undifferentiated malignant neoplasms
Jensen, K. C., Higgins, J. Pt., Montgomery, K., Kaygusuz, G., van de Rijn, M., & Natkunam, Y. (2007). The utility of PAX5 immunohistochemistry in the diagnosis of undifferentiated malignant neoplasms. MODERN PATHOLOGY, 20(8), 871-877.

International standardized approach for flow cytometric residual disease monitoring in chronic lymphocytic leukaemia
Rawstron, A. C., Villamor, N., Ritgen, M., Boettcher, S., Ghia, P., & Hillmen, P. (2007). International standardized approach for flow cytometric residual disease monitoring in chronic lymphocytic leukaemia. LEUKEMIA, 21(5), 956-964.

Oncogenic regulators and substrates of the anaphase promoting complex/cyclosome are frequently overexpressed in malignant tumors
Lehman, N. L., Tibshirani, R., Hsu, J. Y., Natkunam, Y., Harris, B. T., & Jackson, P. K. (2007). Oncogenic regulators and substrates of the anaphase promoting complex/cyclosome are frequently overexpressed in malignant tumors. AMERICAN JOURNAL OF PATHOLOGY, 170(5), 1793-1805.

Mast cell tryptase and microphthalmia transcription factor effectively discriminate cutaneous mast cell disease from myeloid leukemia cutis
Sundram, U. N., & Natkunam, Y. (2007). Mast cell tryptase and microphthalmia transcription factor effectively discriminate cutaneous mast cell disease from myeloid leukemia cutis. JOURNAL OF CUTANEOUS PATHOLOGY, 34(4), 289-295.

Microvessel density and expression of vascular endothelial growth factor and its receptors in diffuse large B-cell lymphoma subtypes
Gratzinger, D., Zhao, S., Marinelli, R. J., Kapp, A. V., Tibshirani, R. J., & Natkunam, Y. (2007). Microvessel density and expression of vascular endothelial growth factor and its receptors in diffuse large B-cell lymphoma subtypes. AMERICAN JOURNAL OF PATHOLOGY, 170(4), 1362-1369.

The oncoprotein LMO2 is expressed in normal germinal-center B cells and in human B-cell lymphomas
Natkunam, Y., Zhao, S., Mason, D. Y., Chen, J., Taidi, B., & Levy, R. (2007). The oncoprotein LMO2 is expressed in normal germinal-center B cells and in human B-cell lymphomas. BLOOD, 109(4), 1636-1642.

Expression of the RNA-binding protein VICKZ in normal hematopoietic tissues and neoplasms
Natkunam, Y., Vainer, G., Chen, J., Zhao, S., Marinelli, R. J., & Lossos, I. S. (2007). Expression of the RNA-binding protein VICKZ in normal hematopoietic tissues and neoplasms. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 92(2), 176-183.

Expression of the human germinal center-associated lymphoma (HGAL) protein identifies a subset of classic Hodgkin lymphoma of germinal center derivation and improved survival
Natkunam, Y., Hsi, E. D., Aoun, P., Zhao, S., Elson, P., & Lossos, I. S. (2007). Expression of the human germinal center-associated lymphoma (HGAL) protein identifies a subset of classic Hodgkin lymphoma of germinal center derivation and improved survival. BLOOD, 109(1), 298-305.

The biology of the germinal center.
Natkunam, Y. (2007). The biology of the germinal center. Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program, 210-215.

Low CD27 expression in plasma cell dyscrasias correlates with high-risk disease: An immunohistochemical analysis
Morgan, T. K., Zhao, S., Chang, K. L., Haddix, T. L., Domanay, E., & Natkunam, Y. (2006). Low CD27 expression in plasma cell dyscrasias correlates with high-risk disease: An immunohistochemical analysis. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 126(4), 545-551.

EBV can protect latently infected B cell lymphomas from death receptor-induced apoptosis
Snow, A. L., Lambert, S. L., Natkunam, Y., Esquivel, C. O., Krams, S. M., & Martinez, O. M. (2006). EBV can protect latently infected B cell lymphomas from death receptor-induced apoptosis. JOURNAL OF IMMUNOLOGY, 177(5), 3283-3293.

Jaw I/LRMP, a germinal centre-associated marker for the immunohistological study of B-cell lymphomas
Tedoldi, S., Paterson, J. C., Cordell, J., Tan, S.-Y., Jones, M., & Marafioti, T. (2006). Jaw I/LRMP, a germinal centre-associated marker for the immunohistological study of B-cell lymphomas. JOURNAL OF PATHOLOGY, 209(4), 454-463.

Prognostic immunohistologic markers in human tumors: why are so few used in clinical practice?
Natkunam, Y., & Mason, D. Y. (2006). Prognostic immunohistologic markers in human tumors: why are so few used in clinical practice?. LABORATORY INVESTIGATION, 86(8), 742-747.

The differential expression of LCK and BAFF-receptor and their role in apoptosis in human lymphomas
Paterson, J. C., Tedoldi, S., Craxton, A., Jones, M., Hansmann, M.-L., & Marafioti, T. (2006). The differential expression of LCK and BAFF-receptor and their role in apoptosis in human lymphomas. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 91(6), 772-780.

CD10 expression in peripheral T-cell lymphomas complicated by a proliferation of large B-cells
Reichard, K. K., Schwartz, E. J., Higgins, J. P., Narasimhan, B., Warnke, R. A., & Natkunam, Y. (2006). CD10 expression in peripheral T-cell lymphomas complicated by a proliferation of large B-cells. MODERN PATHOLOGY, 19(3), 337-343.

Loss of CD19 expression in B-cell neoplasms
Masir, N., Marafioti, T., Jones, M., Natkunam, Y., Rudiger, T., & Mason, D. Y. (2006). Loss of CD19 expression in B-cell neoplasms. HISTOPATHOLOGY, 48(3), 239-246.

Transmembrane adaptor molecules: a new category of lymphoid-cell markers
Tedoldi, S., Paterson, J. C., Hansmann, M. L., Natkunam, Y., Rudiger, T., & HOREJSI, V. (2006). Transmembrane adaptor molecules: a new category of lymphoid-cell markers. BLOOD, 107(1), 213-221.

Utility of syndecan-1 (CD138) expression in the diagnosis of undifferentiated malignant neoplasms - A tissue microarray study of 1,754 cases
Kambham, N., Kong, C., Longacre, T. A., & Natkunam, Y. (2005). Utility of syndecan-1 (CD138) expression in the diagnosis of undifferentiated malignant neoplasms - A tissue microarray study of 1,754 cases. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 13(4), 304-310.

Follicular dendritic cell immunohistochemical markers in angioimmunoblastic T-cell lymphoma
Troxell, M. L., Schwartz, E. J., van de Ruin, M., Ross, D. T., Warnke, R. A., & Natkunam, Y. (2005). Follicular dendritic cell immunohistochemical markers in angioimmunoblastic T-cell lymphoma. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 13(4), 297-303.

TMA-combiner, a simple software tool to permit analysis of replicate cores on tissue microarrays
Liu, C. L., Montgomery, K. D., Natkunam, Y., West, R. B., Nielsen, T. O., & Higgins, J. Pt. (2005). TMA-combiner, a simple software tool to permit analysis of replicate cores on tissue microarrays. MODERN PATHOLOGY, 18(12), 1641-1648.

Cytologic diagnosis of Burkitt lymphoma - Role of ancillary studies
Troxell, M. L., Bangs, C. D., Cherry, A. M., Natkunam, Y., & Kong, C. S. (2005). Cytologic diagnosis of Burkitt lymphoma - Role of ancillary studies. CANCER CYTOPATHOLOGY, 105(5), 310-318.

Treatment of verruca vulgaris with topical cidofovir in an immunlocompromised patient: a case report and review of the literature
Cha, S., Johnston, L., Natkunam, Y., & Brown, J. (2005). Treatment of verruca vulgaris with topical cidofovir in an immunlocompromised patient: a case report and review of the literature. TRANSPLANT INFECTIOUS DISEASE, 7(3-4), 158-161.

Low levels of Her2/neu expressed by Ewing's family tumor cell lines can redirect cytokine-induced killer cells
Verneris, M. R., Arshi, A., Edinger, M., Kornacker, M., Natkunam, Y., & Negrin, R. S. (2005). Low levels of Her2/neu expressed by Ewing's family tumor cell lines can redirect cytokine-induced killer cells. CLINICAL CANCER RESEARCH, 11(12), 4561-4570.

Expression of the human germinal center-associated lymphoma (HGAL) protein, a new marker of germinal center B-cell derivation
Natkunam, Y., Lossos, L. S., Taidi, B., Zhao, S. C., Lu, X. Q., & Levy, R. (2005). Expression of the human germinal center-associated lymphoma (HGAL) protein, a new marker of germinal center B-cell derivation. BLOOD, 105(10), 3979-3986.

Expression pattern of intracellular leukocyte-associated proteins in primary mediastinal B cell lymphoma
Marafioti, T., Pozzobon, M., Hansmann, M. L., Gaulard, P., Barth, T. F., & Mason, D. Y. (2005). Expression pattern of intracellular leukocyte-associated proteins in primary mediastinal B cell lymphoma. LEUKEMIA, 19(5), 856-861.

Expression of CD163 (hemoglobin scavenger receptor) in normal tissues, lymphomas, carcinomas, and sarcomas is largely restricted to the monocyte/macrophage lineage
Nguyen, T. Dt., Schwartz, E. J., West, R. B., Warnke, R. A., Arber, D. A., & Natkunam, Y. (2005). Expression of CD163 (hemoglobin scavenger receptor) in normal tissues, lymphomas, carcinomas, and sarcomas is largely restricted to the monocyte/macrophage lineage. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 29(5), 617-624.

Expression of the bcl-6 and MUM1/IRF4 proteins correlate with overall and disease-specific survival in patients with primary cutaneous large B-cell lymphoma: a tissue microarray study
Sundram, U., Kim, Y., Mraz-Gernhard, S., Hoppe, R., Natkunam, Y., & Kohler, S. (2005). Expression of the bcl-6 and MUM1/IRF4 proteins correlate with overall and disease-specific survival in patients with primary cutaneous large B-cell lymphoma: a tissue microarray study. JOURNAL OF CUTANEOUS PATHOLOGY, 32(3), 227-234.

A novel method for making "tissue" microarrays from small numbers of suspension cells
Montgomery, K., Zhao, S. C., van de Rijn, M., & Natkunam, Y. (2005). A novel method for making "tissue" microarrays from small numbers of suspension cells. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 13(1), 80-84.

The NFATc1 transcription factor is widely expressed in white cells and translocates from the cytoplasm to the nucleus in a subset of human lymphomas
Marafiot, T., Pozzobon, M., Hansmann, M. L., Ventura, R., Pileri, S. A., & Mason, D. Y. (2005). The NFATc1 transcription factor is widely expressed in white cells and translocates from the cytoplasm to the nucleus in a subset of human lymphomas. BRITISH JOURNAL OF HAEMATOLOGY, 128(3), 333-342.

Expression pattern of FCRL (FREB, FcRX) in normal and neoplastic human B cells
Masir, N., Jones, M., Pozzobon, M., Marafioti, T., Volkova, O. Y., & Mason, D. Y. (2004). Expression pattern of FCRL (FREB, FcRX) in normal and neoplastic human B cells. BRITISH JOURNAL OF HAEMATOLOGY, 127(3), 335-343.

Immunophenotypic and genotypic characterization of progression in follicular lymphomas
Natkunam, Y., Soslow, R., Matolcsy, A. A., Dolezal, M., Bhargava, V., & Warnke, R. (2004). Immunophenotypic and genotypic characterization of progression in follicular lymphomas. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 12(2), 97-104.

Intracellular signalling molecules as immunohistochemical markers of normal and neoplastic human leucocytes in routine biopsy samples
Pozzobon, M., Marafioti, T., Hansmann, M. L., Natkunam, Y., & Mason, D. Y. (2004). Intracellular signalling molecules as immunohistochemical markers of normal and neoplastic human leucocytes in routine biopsy samples. BRITISH JOURNAL OF HAEMATOLOGY, 124(4), 519-533.

Atypical cellular disorders.
McClain, K. L., Natkunam, Y., & Swerdlow, S. H. (2004). Atypical cellular disorders. Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program, 283-296.

Characterization of variant patterns of nodular lymphocyte predominant Hodgkin lymphoma with immunohistologic and clinical correlation
Fan, Z., Natkunam, Y., Bair, E., Tibshirani, R., & Warnke, R. A. (2003). Characterization of variant patterns of nodular lymphocyte predominant Hodgkin lymphoma with immunohistologic and clinical correlation. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 27(10), 1346-1356.

Plasmablastic lymphoma presenting in a human immunodeficiency virus-negative patient: a case report
Nguyen, D. D., Loo, B. W., Tillman, G., Natkunam, Y., Cao, T. M., & Advani, R. H. (2003). Plasmablastic lymphoma presenting in a human immunodeficiency virus-negative patient: a case report. ANNALS OF HEMATOLOGY, 82(8), 521-525.

Expression of the B-cell proliferation marker MUM1 by melanocytic lesions and comparison with S100, gp100 (HMB45), and MelanA
Sundram, U., Harvell, J. D., Rouse, R. V., & Natkunam, Y. (2003). Expression of the B-cell proliferation marker MUM1 by melanocytic lesions and comparison with S100, gp100 (HMB45), and MelanA. MODERN PATHOLOGY, 16(8), 802-810.

Rapamycin inhibits the interleukin 10 signal transduction pathway and the growth of Epstein Barr virus B-cell lymphomas
Nepomuceno, R. R., Balatoni, C. E., Natkunam, Y., Snow, A. L., Krams, S. M., & Martinez, O. M. (2003). Rapamycin inhibits the interleukin 10 signal transduction pathway and the growth of Epstein Barr virus B-cell lymphomas. CANCER RESEARCH, 63(15), 4472-4480.

Rituximab in lymphocyte-predominant Hodgkin disease: results of a phase 2 trial
Ekstrand, B. C., Lucas, J. B., Horwitz, S. M., Fan, Z., Breslin, S., & Horning, S. J. (2003). Rituximab in lymphocyte-predominant Hodgkin disease: results of a phase 2 trial. BLOOD, 101(11), 4285-4289.

Software tools for high-throughput analysis and archiving of immunohistochemistry staining data obtained with tissue microarrays
Liu, C. L., Prapong, W., Natkunam, Y., Alizadeh, A., Montgomery, K., & van de Rijn, M. (2002). Software tools for high-throughput analysis and archiving of immunohistochemistry staining data obtained with tissue microarrays. AMERICAN JOURNAL OF PATHOLOGY, 161(5), 1557-1565.

The usefulness of immunohistochemistry in the diagnosis of follicular lymphoma in bone marrow biopsy specimens
West, R. B., Warnke, R. A., & Natkunam, Y. (2002). The usefulness of immunohistochemistry in the diagnosis of follicular lymphoma in bone marrow biopsy specimens. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 117(4), 636-643.

Epstein-Barr virus infection is associated with endothelial bcl-2 expression in transplant liver allografts
Millan, M. T., Natkunam, Y., Clarke-Katzenberg, R., Desai, D., Prapong, W., & Martinez, O. M. (2002). Epstein-Barr virus infection is associated with endothelial bcl-2 expression in transplant liver allografts. TRANSPLANTATION, 73(3), 465-469.

Large atypical cells of lymphomatoid papulosis are CD56-negative: a study of 18 cases
Harvell, J. D., Vaseghi, M., Natkunam, Y., Kohler, S., & Kim, Y. (2002). Large atypical cells of lymphomatoid papulosis are CD56-negative: a study of 18 cases. JOURNAL OF CUTANEOUS PATHOLOGY, 29(2), 88-92.

Apoptosis stimulating protein of p53 (ASPP2) expression differs in diffuse large B-cell and follicular center lymphoma: Correlation with clinical outcome
Lossos, I. S., Natkunam, Y., Levy, R., & Lopez, C. D. (2002). Apoptosis stimulating protein of p53 (ASPP2) expression differs in diffuse large B-cell and follicular center lymphoma: Correlation with clinical outcome. LEUKEMIA & LYMPHOMA, 43(12), 2309-2317.

Durable remission in recurrent T-cell-rich B-cell lymphoma with the anti-CD20 antibody rituximab
Natkunam, Y., Stanton, T. S., Warnke, R. A., & Horning, S. J. (2001). Durable remission in recurrent T-cell-rich B-cell lymphoma with the anti-CD20 antibody rituximab. CLINICAL LYMPHOMA, 2(3), 185-187.

Modified cyclophosphamide, hydroxydaunorubicin, vincristine, and prednisone therapy for posttransplantation lymphoproliferative disease in pediatric patients undergoing solid organ transplantation
Suryanarayan, K., Natkunam, Y., Berry, G., Bangs, C. D., Cherry, A., & Dahl, G. (2001). Modified cyclophosphamide, hydroxydaunorubicin, vincristine, and prednisone therapy for posttransplantation lymphoproliferative disease in pediatric patients undergoing solid organ transplantation. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 23(7), 452-455.

A unique AML1 (CBF2A) rearrangement, t(1;21)(p32;q22), observed in a patient with acute myelomonocytic leukemia
Cherry, A. M., Bangs, C. D., Jones, P., Hall, S., & Natkunam, Y. (2001). A unique AML1 (CBF2A) rearrangement, t(1;21)(p32;q22), observed in a patient with acute myelomonocytic leukemia. CANCER GENETICS AND CYTOGENETICS, 129(2), 155-160.

Expression of a single gene, BCL-6, strongly predicts survival in patients with diffuse large B-cell lymphoma
Lossos, I. S., Jones, C. D., Warnke, R., Natkunam, Y., Kaizer, H., & Levy, R. (2001). Expression of a single gene, BCL-6, strongly predicts survival in patients with diffuse large B-cell lymphoma. BLOOD, 98(4), 945-951.

Analysis of MUM1/IRF4 protein expression using tissue microarrays and immunohistochemistry
Natkunam, Y., Warnke, R. A., Montgomery, K., Falini, B., & van de Rijn, M. (2001). Analysis of MUM1/IRF4 protein expression using tissue microarrays and immunohistochemistry. MODERN PATHOLOGY, 14(7), 686-694.

Natural killer/natural killer-like T-Cell lymphoma, CD56+, presenting in the skin: An increasingly recognized entity with an aggressive course
Mraz-Gernhard, S., Natkunam, Y., Hoppe, R. T., Leboit, P., Kohler, S., & Kim, Y. H. (2001). Natural killer/natural killer-like T-Cell lymphoma, CD56+, presenting in the skin: An increasingly recognized entity with an aggressive course. JOURNAL OF CLINICAL ONCOLOGY, 19(8), 2179-2188.

Natural killer cell precursor acute lymphoma/leukemia presenting in an infant
Natkunam, Y., Cherry, A. M., & Cornbleet, P. J. (2001). Natural killer cell precursor acute lymphoma/leukemia presenting in an infant. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 125(3), 413-418.

Angiocentric lymphomas (lymphomatous vasculitis)
Natkunam, Y., & Warnke, R. A. (2001). Angiocentric lymphomas (lymphomatous vasculitis). SEMINARS IN DIAGNOSTIC PATHOLOGY, 18(1), 67-77.

Co-expression of CD56 and CD30 in lymphomas with primary presentation in the skin: clinicopathologic, immunohistochemical and molecular analyses of seven cases
Natkunam, Y., Warnke, R. A., Haghighi, B., Su, L. D., Le Boit, P. E., & Kohler, S. (2000). Co-expression of CD56 and CD30 in lymphomas with primary presentation in the skin: clinicopathologic, immunohistochemical and molecular analyses of seven cases. JOURNAL OF CUTANEOUS PATHOLOGY, 27(8), 392-399.

Blastic/blastoid transformation of follicular lymphoma - Immunohistologic and molecular analyses of five cases
Natkunam, Y., Warnke, R. A., Zehnder, J. L., Jones, C. D., Milatovich-Cherry, A., & Cornbleet, P. J. (2000). Blastic/blastoid transformation of follicular lymphoma - Immunohistologic and molecular analyses of five cases. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 24(4), 525-534.

Utility of paraffin section immunohistochemistry for C-KIT (CD117) in the differential diagnosis of systemic mast cell disease involving the bone marrow
Natkunam, Y., & Rouse, R. V. (2000). Utility of paraffin section immunohistochemistry for C-KIT (CD117) in the differential diagnosis of systemic mast cell disease involving the bone marrow. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 24(1), 81-91.

Immunoblot analysis of CD34 expression in histologically diverse neoplasms
Natkunam, Y., Rouse, R. V., Zhu, S., Fisher, C., & van de Rijn, M. (2000). Immunoblot analysis of CD34 expression in histologically diverse neoplasms. AMERICAN JOURNAL OF PATHOLOGY, 156(1), 21-27.

Aggressive cutaneous NK and NK-like T-cell lymphomas - Clinicopathologic, immunohistochemical, and molecular analyses of 12 cases
Natkunam, Y., SMOLLER, B. R., Zehnder, J. L., Dorfman, R. F., & Warnke, R. A. (1999). Aggressive cutaneous NK and NK-like T-cell lymphomas - Clinicopathologic, immunohistochemical, and molecular analyses of 12 cases. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 23(5), 571-581.

Aggressive natural killer-like T-cell malignancy with leukemic presentation following solid organ transplantation
Natkunam, Y., Warnke, R. A., Zehnder, J. L., & Cornbleet, P. J. (1999). Aggressive natural killer-like T-cell malignancy with leukemic presentation following solid organ transplantation. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 111(5), 663-671.

Epstein-Barr virus strain type and latent membrane protein 1 gene deletions in lymphomas in patients with rheumatic diseases
Natkunam, Y., ElenitobaJohnson, K. S., Kingma, D. W., & Kamel, O. W. (1997). Epstein-Barr virus strain type and latent membrane protein 1 gene deletions in lymphomas in patients with rheumatic diseases. ARTHRITIS AND RHEUMATISM, 40(6), 1152-1156.

SIMULTANEOUS ACTIVATION OF IG AND OCT-2 SYNTHESIS AND REDUCTION OF SURFACE MHC CLASS-II EXPRESSION BY IL-6
Natkunam, Y., Zhang, X. K., Liu, Z. Y., & CHENKIANG, S. (1994). SIMULTANEOUS ACTIVATION OF IG AND OCT-2 SYNTHESIS AND REDUCTION OF SURFACE MHC CLASS-II EXPRESSION BY IL-6. JOURNAL OF IMMUNOLOGY, 153(8), 3476-3484.

NUCLEAR SIGNALING BY INTERLEUKIN-6
CHENKIANG, S., Hsu, W., Natkunam, Y., & Zhang, X. K. (1993). NUCLEAR SIGNALING BY INTERLEUKIN-6. CURRENT OPINION IN IMMUNOLOGY, 5(1), 124-128.